BRIAN TAFT: Open Payments
NPI 1184142606 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 53 payments from 16 companies in 2025. Trend: 2023 $17 · 2024 $437 · 2025 $1,053
Food & beverage: $1,053
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $427 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Corcept Therapeutics | 3 | $63 |
| Lilly USA, LLC | 3 | $51 |
| Amgen Inc. | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 3 | $46 |
| Exact Sciences Corporation | 2 | $36 |
| Novo Nordisk Inc | 2 | $33 |
Products named: UBRELVY, LEQVIO, REXULTI, Korlym, QULIPTA, MOUNJARO, KRYSTEXXA, VOQUEZNA.
Industry payments across ID — which companies pay providers there.
